Sarepta Therapeutics Inc logo

Sarepta Therapeutics Inc

$ 79.95 (0%) Aug 16
P/E:
At Loss
P/B:
13.14
Market Cap:
$ 9.55B
Enterprise V:
$ 8.76B
Volume:
-
Avg Vol (2M):
-
Also Trade In:
Volume:
-
Market Cap $:
9.55B
PE Ratio:
At Loss
Avg Vol (2-Month):
-
Enterprise Value $:
8.76B
PB Ratio:
13.14
GF Score:
Year:
EMBED
To
10Y: -%
Above Low: +NaN%
Below High: NaN%
Alerts Website Sources Stock Report
Dataset
Financial Download Tutorials

Business Description

Sarepta Therapeutics Inc
NAICS : 325412 SIC : 2834
215 First Street, Suite 415, Cambridge, MA, USA, 02142
Description
Sarepta Therapeutics is a biotechnology company focused on treating rare, infectious, and other diseases. It targets a broad range of diseases while focusing on the rapid development of its drug candidates. Sarepta's strategy involves proprietary RNA-targeted technology platforms to be used for developing novel pharmaceutical products to treat a broad range of diseases and address key unmet medical needs. The company uses third-party contractors to manufacture its product candidates. Most of Sarepta's product candidates are at an early stage of development.
Name Current Vs Industry Vs History
Cash-To-Debt 1.69
Equity-to-Asset 0.24
Debt-to-Equity 1.57
Debt-to-EBITDA -2.87
Piotroski F-Score 4/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 1.43
Distress
Grey
Safe
Beneish M-Score -2.2
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
12-1 Month Momentum % -0.57

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 4.53
Quick Ratio 4.14
Cash Ratio 3.53
Days Inventory 675.01
Days Sales Outstanding 70.92
Days Payable 180.58

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -7

Financials (Next Earnings Date:2022-11-03 Est.)

LTS:0L35's 30-Y Financials

Guru Trades

See Details
To
EMBED
SAVE

Insider Trades

See Details
To
EMBED
SAVE

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To
EMBED
SAVE
Dividend
To
EMBED
SAVE

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

Valuation Box

Year:
EMBED

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 835.184
EPS (TTM) ($) -5.88
Beta 0.96
Volatility % 11.85
14-Day RSI 0
14-Day ATR ($) 0.000007
20-Day SMA ($) 79.95
12-1 Month Momentum % -0.57
52-Week Range ($) 77.953 - 80.25
Shares Outstanding (Mil) 87.57

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 4
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Sarepta Therapeutics Inc Filings

Document Form Filing Date
No Filing Data